Effetto | Estimate | S.E. | Pr > |t| |
---|---|---|---|
Intercept | 36.85 | 10.17 | < 0.001 |
Treatment E + Hy | 3.85 | 3.33 | 0.25 |
Treatment ESWT-al (reference group) | |||
Time Follow-up 2 | −18.13 | 2.59 | < 0.001 |
Time Follow-up 1 | −16.62 | 2.58 | < 0.001 |
Baseline (reference group) | |||
Time Follow-up 2 Treatment E + Hy | −13.22 | 2.96 | < 0.001 |
Time Follow-up 2 Treatment ESWT-al (reference group) | |||
Time Follow-up 1 Treatment E + Hy | −10.43 | 2.95 | < 0.001 |
Time Follow-up 1 Treatment ESWT-al (reference group) | |||
Baseline (reference group) | |||
Sex Male | 3.87 | 3.23 | 0.24 |
Sex Female (reference group) | |||
Time Follow-up 2 Sex Male | −5.73 | 2.95 | 0.05 |
Time Follow-up 2 Sex Female (reference group) | |||
Time Follow-up 1 Sex Male | 3.49 | 2.92 | 0.24 |
Time Follow-up 1 Sex Female (reference group) | |||
Shoulder pain side right | −4.90 | 2.90 | 0.10 |
Shoulder pain side left (reference group) | |||
Age (yy) | 0.19 | 0.20 | 0.34 |